Literature DB >> 2273543

[Effects of lumbar or thoracic epidural anesthesia on median nerve somatosensory evoked potentials].

T Kasaba1, T Nonoue, T Yanagidani, M Maeda, Y Kosaka.   

Abstract

Somatosensory evoked potentials (SSEP) are used increasingly to monitor the integrity of neural pathways in anesthetized patients. To evaluate the influence of epidural anesthesia on the central nervous system, we studied the effects of lumbar or thoracic epidural anesthesia with lidocaine on the median nerve SSEP in 9 patients. The peak latencies (N1, P2, N2) and amplitudes (N1-P2, P2-N2) of the SSEP response over the sensory cortex were recorded before and 15 min after epidural anesthesia. The peak latencies of control and post epidural anesthesia of N1, P1, N2 were 19.2 +/- 1.7 msec, 19.6 +/- 1.6 msec (N1), 24.7 +/- 2.3 msec, 25.7 +/- 2.0 msec (P2), 32.8 +/- 2.8 msec and 34.6 +/- 2.5 msec (N2), respectively. The amplitude of control and post epidural anesthesia of N1-P2, P2-N2 were 4.5 +/- 2.9 microV, 5.9 +/- 6.6 microV (N1-P2), 4.4 +/- 3.2 microV and 5.6 +/- 5.2 microV (P2-N2), respectively. Peak latencies of all components (L1, P2, N2) increased after epidural anesthesia compared with control values. Amplitude of N1-P2 increased significantly following epidural anesthesia compared with control values. The data obtained in this study were contrary to the previous concept that anesthetic agents generally increase the latency of SSEP and decrease their amplitude.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2273543

Source DB:  PubMed          Journal:  Masui        ISSN: 0021-4892


  2 in total

1.  Systemic lidocaine and human somatosensory-evoked potentials during sufentanil-isoflurane anaesthesia.

Authors:  A Schubert; M G Licina; G M Glaze; L Paranandi
Journal:  Can J Anaesth       Date:  1992-07       Impact factor: 5.063

2.  Effects of abdominal surgery on somatosensory evoked potentials during nitrous oxide-enflurane anesthesia.

Authors:  T Kasaba; Y Kosaka
Journal:  J Anesth       Date:  1991-07       Impact factor: 2.078

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.